Becton Dickinson & Co.: Device Recall

Recall #Z-2023-2024 · 05/07/2024

Class II: Risk

Recall Details

Recall Number
Z-2023-2024
Classification
Class II
Product Type
Device
Recalling Firm
Becton Dickinson & Co.
Status
Ongoing
Date Initiated
05/07/2024
Location
Sparks, MD, United States
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2,061 kits

Reason for Recall

Assays may produce false negative results due to decreased activity of the enzyme utilized in manufacturing.

Product Description

BD SARS-CoV-2 Reagents for BD MAX" Systems. RT-PCR test to detect SARS-CoV-2 in nasal, nasopharyngeal, oropharyngeal swab specimens, and saliva specimens.

Distribution Pattern

Domestic: Nationwide Distribution; Foreign: AU, BR, BE, CA, CO, & JP.

Other Recalls by Becton Dickinson & Co.

View all recalls by Becton Dickinson & Co. →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.